|
Scientist Create First Manmade Genome |
|
Friday, 21 May 2010 |
As reported in Bloomberg Businessweek on May 21, 2010 - Researchers from J. Craig Venter Institute reported in Science journal that they have successfully transplanted a bacterium's complete genome into a related organism. The implications of this discovery are both exciting and frightening; while this discovery will allow us to create new drugs and fuels, it may also open the door to new viruses that can easily be exploited by bioterrorists.
|
|
Read more...
|
|
NIH discovers bone stem cells |
|
Wednesday, 28 April 2010 |
Researchers at the National Institutes of Health have pinpointed locations of stem cells growing in mice at the spine, at the end of shins and in other bones. While researchers have known that stem cells found in bone marrow become blood cells, this is the first discovery of stem cells that give rise to supportive or structural tissue. This is an exciting discovery that could potentially lead to the ability to repair damaged or malformed bones, and ultimately further educate scientists on the formation of bone tumors.
|
|
Read more...
|
|
|
|
|
Pfizer developed reagents to be distributed by Stemgent under new partnership |
|
Wednesday, 21 April 2010 |
|
As reported by the Associated Press on April 15, 2010, Pfizer Inc. said Thursday it will partner with reagent maker Stemgent Inc. to make new reagents available to researchers.
Reagents developed or discovered by Pfizer will be sold to
researchers by Stemgent, the companies said. They said the reagents and
other Stemgent products could help scientists working on stem cell and
cell-based research in fields such as neuroscience, cancer, and
metabolic diseases. The reagents are intended for use in non-human
experiments.
Financial terms of the agreement were not disclosed.
Pfizer shares dipped 8 cents to close at $16.99.
|
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
|
